Earnings History Data for RVL Pharmaceuticals plc (RVLP) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
RVL Pharmaceuticals plc
RVL Pharmaceuticals plc is a specialty pharmaceutical company. It focused on the commercialization and development of products which target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas. RVL Pharmaceuticals plc, formerly known as Osmotica Pharmaceuticals plc, is based in BRIDGEWATER, N.J.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14-08-2023 | PM | RVLP | RVL Pharmaceuticals plc | 48.44 | -0.13 | -0.13 | -0.19 | RVL Pharmaceuticals plc GAAP EPS of -$0.24 misses by $0.12, revenue of $8.26M misses by $1.99M [8/14/2023 6:54 AM] |
0.3810 | -0.08 (-16.83%) |
0.46 | 0.0 (0.41%) |
0.36 - 2.99 | 207,382 | 80,000 | 2,188 | ||
| 11-05-2023 | PM | Before the open (May 11) |
RVLP | RVL Pharmaceuticals plc | 82.45 | -0.12 | -0.12 | -0.13 | RVL Pharmaceuticals plc GAAP EPS of -$0.12 in-line, revenue of $8.83M misses by $0.37M [5/11/2023 6:51 AM] |
0.8880 | 0.04 (4.41%) |
0.0 | 0.0 (0.00%) |
0.72 - 2.99 | 44,032 | 90,000 | 0 | |
| 20-03-2023 | PM | Before the open (Mar 20) |
RVLP | RVL Pharmaceuticals plc | 128.04 | -0.18 | -0.15 | -0.26 | RVL Pharmaceuticals plc GAAP EPS of -$0.18 misses by $0.01, revenue of $9.81M misses by $2.72M [3/20/2023 7:07 AM] |
1.07 | -0.25 (-18.56%) |
1.11 | -0.21 (-15.91%) |
0.99 - 2.99 | 222,044 | 30,000 | 1,551 | |
| 10-11-2022 | AH | 4:05 PM ET (Nov 10) |
RVLP | RVL Pharmaceuticals plc | 157.65 | -0.16 | -0.19 | -0.42 | RVL Pharmaceuticals plc GAAP EPS of -$0.16 in-line, revenue of $10.02M in-line [11/10/2022 4:18 PM] |
1.44 | 0.0 (0.00%) |
0.0 | 0.0 (0.00%) |
0.98 - 2.99 | 148,519 | 70,000 | 0 | |
| 11-08-2022 | PM | 6:50 AM ET (Aug 11) |
RVLP | RVL Pharmaceuticals plc | 115.38 | -0.19 | -0.23 | -0.15 | GAAP EPS of -$0.14 beats by $0.07, revenue of $8.45M misses by $0.07M [8/11/2022 6:57 AM] |
1.84 | -0.03 (-1.86%) |
1.98 | 0.10 (5.59%) |
0.98 - 4.38 | 185,594 | 110,000 | 1,449 | |
| 12-05-2022 | PM | Before the open (May 12) |
RVLP | RVL Pharmaceuticals plc | 116.13 | -0.13 | -0.25 | -0.15 | GAAP EPS of -$0.08 beats by $0.13, revenue of $21.4M beats by $14.6M [5/12/2022 6:52 AM] |
1.39 | -0.02 (-1.42%) |
0.0 | 0.0 (0.00%) |
0.98 - 4.85 | 114,949 | 100,000 | 0 | |
| 30-03-2022 | AH | After the close (Mar 30) |
RVLP | RVL Pharmaceuticals plc | 149.92 | -0.26 | -0.28 | -0.26 | reports Q4 results [3/30/2022 4:21 PM] |
1.71 | -0.04 (-2.29%) |
1.67 | -0.08 (-4.57%) |
0.98 - 4.85 | 217,560 | 180,000 | 10,601 | |